Early Neutropenic Fever De-escalation of Antibiotics Study

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2028

Conditions
Hematologic MalignancyFebrile NeutropeniaAntibiotic Stewardship
Interventions
DRUG

Cessation of antibiotics

Stop antibiotic therapy after episode of fever if afebrile for 48 hours, no clinically documented source of bacterial infection, and no hemodynamic or respiratory decompensation.

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Brigham and Women's Hospital

OTHER